Overview

Infusion of Expanded Cord Blood T Cells

Status:
Withdrawn
Trial end date:
2011-09-01
Target enrollment:
Participant gender:
Summary
The goal of this clinical research study is to learn if treating umbilical cord blood with growth factors before a transplant can help to improve the body's ability to accept the cord blood transplants.
Phase:
Phase 1
Details
Lead Sponsor:
M.D. Anderson Cancer Center
Treatments:
Antilymphocyte Serum
Etoposide
Etoposide phosphate
Fludarabine
Fludarabine phosphate
Lenograstim
Melphalan
Mycophenolate mofetil
Mycophenolic Acid
Rituximab
Tacrolimus
Thiotepa
Vidarabine